Related Experiment Video
Updated: Apr 26, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Effects of antibiotic consumption on children 2-8 years of age developing asthma
Hamid Reza Khalkhali1, Sima Oshnouei2, Shaker Salarilak3
1Inpatient Safety Research Center, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran ; Department of Biostatistics and Epidemiology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Insights
Antibiotic use in early childhood is linked to a higher risk of developing asthma. This study found a significant association between antibiotic consumption in the first year of life and increased odds of childhood asthma.
Area of Science:
- Pediatric Medicine
- Epidemiology
- Public Health
Background:
- Childhood asthma prevalence is rising globally.
- Antibiotic exposure is a suspected environmental factor contributing to this increase.
Purpose of the Study:
- To investigate the association between antibiotic exposure and childhood asthma risk.
- To determine if early-life antibiotic use impacts asthma development in children aged 2-8 years.
Main Methods:
- A case-control study was conducted in Iran involving 207 asthmatic children (cases) and 400 healthy children (controls) aged 2-8 years.
- Data on antibiotic exposure and other risk factors were collected via parental interviews using a validated questionnaire.
- Cases were diagnosed based on Global Initiative for Asthma criteria; controls were matched for age and gender.
Main Results:
- Antibiotic consumption during the first year of life was associated with a significantly increased odds ratio (OR) for asthma symptoms (adjusted OR, 1.91; 95% CI, 1.27-2.88).
- This association remained significant after adjusting for potential confounders like family history of asthma, preterm delivery, and birth order.
Conclusions:
- Early-life antibiotic consumption in children is associated with an elevated risk of developing childhood asthma.
- Further research is recommended to confirm these findings and explore underlying mechanisms.
Objectives:
Antibiotic exposure in children is a possible contributor to the increasing asthma prevalence in several countries. The present study aimed to investigate the association between antibiotic exposure and the risk of developing childhood asthma at 2-8 years of age.
Methods:
A case-control study was undertaken among children aged 2-8 years old between March and September 2010 in the Urmia district in the northwest of Iran. The cases were doctor-diagnosed asthmatic children based on Global Initiative for Asthma criteria (n=207), and the controls were children without respiratory symptoms (n=400) selected by frequency matching by age and gender. Clinical data including antibiotic exposure was collected by a validated and reliable questionnaire, which was completed by interviewing parents/guardians.
Results:
Antibiotic consumption during the first year of life increased the odds ratio [OR] of asthma symptoms at 2-8 years of age (crude OR, 2.26; 95% confidence interval [CI], 1.53-3.35; p<0.01), and the strength of association was similar after adjusting for a family history of asthma or atopic disorder, preterm delivery, birth order, and delivery method (adjusted OR, 1.91; 95% CI, 1.27-2.88; p=0.03).
Conclusions:
Our study suggests that antibiotic consumption in children was associated with an increased risk of childhood asthma, and an additional confirmative study is needed.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Related Concept Videos
Asthma I: Introduction
Asthma-I: Introduction
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Asthma-III: Symptoms and Complications
Classification of Asthma
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...